Name: Unleashing the Power of Gene Therapy for a Broad Universe of Diseases by The Bioverge Podcast
Duration: 53 min 6 s
Description: Kriya Therapeutics Co-Founder, Chairman, and CEO Shankar Ramaswamy sits down with Neil. He discusses how the company is changing the way gene therapies are designed, developed, and manufactured in an effort to cut costs, accelerate the time to market, and expand the reach of gene therapies to a broad universe of disease.

Anthony DePasqua, CEO of EnClear Therapies, sits down with Neil to discuss the company’s technology in development to remove toxic proteins from cerebrospinal spinal fluid to treat patients with ALS and other neurodegenerative conditions.

Removing Toxins from Cerebrospinal Fluid to Treat Neurodegenerative Diseases

Kriya Therapeutics Co-Founder, Chairman, and CEO Shankar Ramaswamy sits down with Neil. He discusses how the company is changing the way gene therapies are designed, developed, and manufactured in an effort to cut costs, accelerate the time to market, and expand the reach of gene therapies to a broad universe of disease.

Unleashing the Power of Gene Therapy for a Broad Universe of Diseases

Join Neil Littman on The Bioverge Podcast as he explores the intersection of bio x tech and features the entrepreneurs, investors, and industry leaders who are revolutionizing healthcare and bringing science fiction to life.

Unleashing the Power of Gene Therapy for a Broad Universe of Diseases

The Bioverge Podcast

Related tracks